MedPath
TGA Approval

EUG-IRINOTECAN irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439202)

439202

EUG-IRINOTECAN irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial

Eugia Pharma (Australia) Pty Ltd

March 17, 2025

Medicine

Medicine

Active

Registered

Active Ingredients

irinotecan hydrochloride trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EUG-IRINOTECAN irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial (439202) - TGA 批准文号 | MedPath